Rallybio Corporation (RLYB) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts RLYB Hot Sheet
Join SI Premium – FREE
Rallybio Corporation (NASDAQ: RLYB) reported Q1 EPS of ($0.21), $0.07 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $20 thousand.
For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Braveheart Bio (BRVE) at Overweight
- Mizuho Downgrades Sempra Energy (SRE) to Neutral
- Evercore ISI Starts Red Cat Holdings Inc. (RCAT) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
